Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

596
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
596
Depression: Overview01:18

Depression: Overview

569
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
569
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

334
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
334
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

276
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
276
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

1.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.1K
Long-term Depression01:05

Long-term Depression

32.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Amygdala and hippocampal volumes as neural correlates of resilience and loneliness in older adults.

Neurobiology of aging·2026
Same author

Simulation of long-term lecanemab treatment effect on Alzheimer's disease progression.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Angiogenesis markers and cognitive response in a randomized trial of cognitive remediation plus transcranial direct current stimulation in older adults at risk of dementia.

Journal of Alzheimer's disease : JAD·2026
Same author

Brain Structures and Cognitive Decline: Moderation Analysis of the PACt-MD Randomized Clinical Trial of Brain Stimulation Plus Cognitive Remediation in Older Adults With Remitted Depression or Mild Cognitive Impairment.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same author

Synaptic biomarkers in Alzheimer's disease dementia and mild cognitive impairment: A systematic review and meta-analysis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trial.

Alzheimer's research & therapy·2026

Related Experiment Videos

Zinc in depression: a meta-analysis.

Walter Swardfager1, Nathan Herrmann, Graham Mazereeuw

  • 1Neuropsychopharmacology Research Group, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada; Toronto Rehabilitation Institute, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.

Biological Psychiatry
|June 29, 2013
PubMed
Summary
This summary is machine-generated.

Depression is linked to lower zinc levels in the blood. This meta-analysis confirms a significant zinc deficiency in depressed individuals, suggesting further research into zinc supplementation for depression is warranted.

Keywords:
Depressiondepressive symptomsmajor depressive disordermicronutrienttrace metalzinc

Related Experiment Videos

Area of Science:

  • Nutritional Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Zinc is a vital micronutrient crucial for numerous biological functions, including cell growth, metabolism, and immune regulation.
  • Dysregulation of zinc homeostasis is increasingly implicated in the pathophysiology of depression.
  • Understanding the role of zinc in mental health is essential for developing novel therapeutic strategies.

Purpose of the Study:

  • To quantitatively synthesize existing clinical data comparing peripheral blood zinc concentrations between individuals with and without depression.
  • To determine the overall effect size of zinc levels in depression through meta-analysis.
  • To explore factors influencing the relationship between zinc status and depression severity.

Main Methods:

  • A systematic literature search was conducted across PubMed, CINAHL, and PsycINFO for relevant studies published up to June 2012.
  • Seventeen studies, including 1643 depressed subjects and 804 controls, were included in the meta-analysis.
  • Random-effects meta-analysis was employed to calculate the weighted mean difference (WMD) in zinc concentrations.

Main Results:

  • Depressed subjects exhibited significantly lower peripheral blood zinc concentrations compared to non-depressed controls (WMD = -1.85 µmol/L).
  • Greater depression severity correlated with more pronounced zinc deficiency.
  • Higher methodological quality and inpatient studies reported larger effect sizes for zinc deficiency.

Conclusions:

  • A consistent association exists between depression and reduced peripheral blood zinc levels.
  • The findings underscore the importance of zinc status in depression.
  • Further research is recommended to elucidate the causal relationship and explore the therapeutic potential of zinc supplementation in managing depression.